BIIB vs RPD · P/E 21, rev $9.89B vs P/E 59, rev $420.6M
Biogen Inc (BIIB) versus Rapid7 Inc (RPD) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Rapid7 Inc (RPD) is a software - infrastructure company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported RPD revenue for 2026-06-30 was $420.6M. Net income was $7.2M. RPD currently screens at market cap $1.57B and trailing P/E 59.4.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. RPD currently screens at market cap $1.57B and trailing P/E 59.4.
Not investment advice. Open the BIIB and RPD stock pages for the full models.
Not investment advice.